Tumor Sphere Formation Assay
Corresponding Organization :
Other organizations : Massachusetts Institute of Technology, Graz University of Technology, Medical University of Graz, Dana-Farber Cancer Institute, Innsbruck Medical University, Universität Innsbruck, Harvard University, Beth Israel Deaconess Medical Center, The University of Texas MD Anderson Cancer Center, BioTechMed-Graz
Variable analysis
- Gene expression levels
- Tumor sphere formation
- Dissociation of adherent growing cell lines into single cells using trypsin/EDTA
- Seeding of 2000 single cells per well in ultra-low attachment 6-well plates
- Use of serum-free MEBM medium (SFM) supplemented with 1xB27 supplement, 20 ng/ml human epidermal growth factor EGF, 10 ng/ml human basic fibroblast growth factor FGF, 20 IU/ml heparin, and 1% antibiotic/antimycotic solution
- Incubation for 14 days
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!